Valuation: Almirall, S.A.

Market Cap 2.45B 2.8B 2.26B 2.09B 3.96B 267B 4.02B 26.98B 10.59B 131B 10.51B 10.28B 452B P/E 2026 *
28x
P/E 2027 * 19.9x
Enterprise Value 2.33B 2.66B 2.15B 1.99B 3.77B 254B 3.83B 25.68B 10.09B 125B 10B 9.79B 430B EV / Sales 2026 *
1.89x
EV / Sales 2027 * 1.63x
Free-Float
35.93%
Yield 2026 *
1.74%
Yield 2027 * 1.91%
1 day-2.09%
1 week-1.40%
Current month-0.18%
1 month+0.36%
3 months-13.54%
6 months-14.72%
Current year-12.46%
1 week 11.24
Extreme 11.24
11.8
1 month 11
Extreme 11
11.8
Current year 10.82
Extreme 10.82
13.98
1 year 10.06
Extreme 10.06
13.98
3 years 7.74
Extreme 7.74
13.98
5 years 7.16
Extreme 7.16
15.35
10 years 7.16
Extreme 7.16
18.5
Manager TitleAgeSince
Chief Executive Officer - 2022-11-01
Director of Finance/CFO 53 2025-08-30
Chief Tech/Sci/R&D Officer - 2021-07-06
Director TitleAgeSince
Director/Board Member 58 2026-05-07
Director/Board Member - 2015-12-31
Director/Board Member 67 2020-06-30
Date Insider Type Main position Quantity % Market Cap.
23-06-22Buy

Executive/Senior Manager

3,000 0.0017%
23-06-21Buy

Executive/Senior Manager

5,000 0.0028%
23-06-21Buy 4,340 0.0024%
Change 5-day change 1-year change 3-year change Capi.($)
-2.09%-1.40%+2.74%+44.01% 2.8B
-2.33%-2.09%+49.88%+170.51% 1,060B
-0.82%-2.30%+63.79%+62.00% 619B
-0.73%-4.98%+28.91%+82.99% 438B
+0.33%-1.17%+31.07%+27.09% 333B
-0.02%-2.85%+29.15%+45.24% 282B
-3.89%-11.22%+22.81%+27.30% 267B
+0.66%-1.42%-26.59%-37.71% 218B
-0.06%-2.88%+23.07%+62.33% 196B
-3.72%-1.10%+18.41%+70.56% 161B
Average -1.27%-3.06%+24.33%+55.43% 357.67B
Weighted average by Cap. -1.32%-2.96%+36.72%+83.88%

Financials

2026 *2027 *
Net sales 1.23B 1.41B 1.13B 1.05B 1.99B 134B 2.02B 13.56B 5.32B 66.08B 5.28B 5.17B 227B 1.36B 1.56B 1.26B 1.16B 2.2B 149B 2.24B 15.03B 5.9B 73.24B 5.85B 5.73B 252B
Net income 85.83M 98.12M 79.16M 73.12M 139M 9.36B 141M 946M 371M 4.61B 368M 360M 15.85B 121M 138M 112M 103M 196M 13.2B 199M 1.33B 524M 6.5B 520M 508M 22.36B
Net Debt -117M -134M -108M -99.91M -190M -12.79B -193M -1.29B -508M -6.3B -503M -492M -21.66B -231M -265M -214M -197M -374M -25.24B -380M -2.55B -1B -12.43B -994M -972M -42.74B
Logo Almirall, S.A.
Almirall SA is a Spain-based company principally engaged in the pharmaceuticals manufacture. The Company focuses on development and marketing of drugs applied in various therapeutic areas, such as nervous system, gastrointestinal, dermatological, respiratory system, antiinfectives, as well as antineoplastic and immunomodulating agents. The Company's activities are divided into four business segments: Own network, which focuses on the commercialization of pharmaceuticals through own brand names; Licenses, which sells product rights to third parties; Research and development (R&D), which is responsible for the creation of drug candidates, as well as Dermatology, which includes sale of dermatological medicines in the United States. The Company operates through numerous subsidiaries in Europe, the Americas, Africa, Asia and Australia.
Employees
2,108
Date Price Change Volume
26-07-10 €11.24 -2.09% 73,969
26-07-09 €11.48 +0.17% 69,857
26-07-08 €11.46 -2.05% 92,222
26-07-07 €11.70 +1.74% 141,384
26-07-06 €11.50 +0.88% 111,704
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
12
Last Close Price
11.24EUR
Average target price
14.58EUR
Spread / Average Target
+29.67%

Quarterly revenue - Rate of surprise